publication date: Jun. 29, 2018

Senate committee proposes $2 billion raise for NIH, signaling fourth good year in a row

By Jordan Williams and Matthew Bin Han Ong

When the Senate Committee on Appropriations marked up the fiscal 2019 spending bill, NIH came out ahead—$2 billion ahead.

Under the Senate bill, which was marked up June 28, NIH would receive $39.1 billion. If the bill is enacted, federally-funded biomedical research would get its fourth consecutive increase, and a substantial one at that.

Of the proposed $2 billion, $190 million in new money would trickle down to NCI.

The House version of the Labor-HHS spending bill, published June 14, proposes a $1.25 billion increase for NIH, bringing the total to $38.3 billion.

The president’s budget proposal initially sought to cut NIH budget by 27 percent, but after Congress raised the spending caps, the White House largely reversed the cut, adding back $9 billion, thereby bringing NIH funding back to the FY 2017 level (The Cancer Letter, Feb. 16).

Here is how the numbers line up for NCI:

In the Senate bill, NCI stands to receive $6.15 billion, with $400 million in Cancer Moonshot funds coming from the NIH Innovation Account. The bill also includes $30 million for NCI’s facility in Frederick.

In the House bill, NCI would receive $6.13 billion, also with the Moonshot included.

Under the White House proposal, NCI would get $5.626 billion. This number, too, includes the Moonshot.


“Congress is hard at work … Continue reading Senate committee proposes $2 billion raise for NIH, signaling fourth good year in a row

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.